{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T04:01:06Z","timestamp":1778904066956,"version":"3.51.4"},"reference-count":103,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parasitology International"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.parint.2021.102298","type":"journal-article","created":{"date-parts":[[2021,2,5]],"date-time":"2021-02-05T11:11:43Z","timestamp":1612523503000},"page":"102298","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Antiparasitic antibiotics from Japan"],"prefix":"10.1016","volume":"82","author":[{"given":"Kazuro","family":"Shiomi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.parint.2021.102298_bb0005","author":"Centers for Disease Control and Prevention"},{"issue":"6","key":"10.1016\/j.parint.2021.102298_bb0010","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1002\/anie.200400663","article-title":"The quest for quinine: those who won the battles and those who won the war","volume":"44","author":"Kaufman","year":"2005","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.parint.2021.102298_bb0015","series-title":"Antibiotics III, Mechanism of Action of Antimicrobial and Antitumor Agents","first-page":"420","article-title":"Emetine and related alkaloids","author":"Grollman","year":"1975"},{"key":"10.1016\/j.parint.2021.102298_bb0020","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2174\/1874315300801010031","article-title":"Tetracycline antibiotics in malaria","volume":"1","author":"Briolant","year":"2008","journal-title":"Open Trop. Med. J."},{"key":"10.1016\/j.parint.2021.102298_bb0025","first-page":"505","article-title":"Trichomycin, a new antibiotic produced by Streptomyces hachijoensis with trichomonadicidal and antifungal activity","volume":"22","author":"Hosoya","year":"1952","journal-title":"Jpn. J. Exp. Med."},{"issue":"4","key":"10.1016\/j.parint.2021.102298_bb0030","first-page":"182","article-title":"A new antibiotic, azomycin","volume":"6","author":"Maeda","year":"1953","journal-title":"J. Antibiot. Ser. A"},{"issue":"9","key":"10.1016\/j.parint.2021.102298_bb0035","first-page":"618","article-title":"Antiamebic and antitrichomonal studies on the antibiotic paromomycin (humatin) in vitro and in experimental animals","author":"Thompson","year":"1959","journal-title":"Antibiot. Chemother."},{"key":"10.1016\/j.parint.2021.102298_bb0040","doi-asserted-by":"crossref","first-page":"742","DOI":"10.3181\/00379727-101-25080","article-title":"Some compounds active against experimental visceral leishmaniasis","volume":"101","author":"Cappuccino","year":"1959","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"10.1016\/j.parint.2021.102298_bb0045","first-page":"883","article-title":"The antiparasitic activity of the antibiotic hygromycin","author":"McCowen","year":"1956","journal-title":"Antibiot. Annu."},{"issue":"29","key":"10.1016\/j.parint.2021.102298_bb0050","doi-asserted-by":"crossref","first-page":"3813","DOI":"10.1016\/S0040-4039(01)80664-X","article-title":"Structure of trichomycin A, a polyene macrolide from streptomyces","volume":"30","author":"Komori","year":"1989","journal-title":"Tetrahedron Lett."},{"issue":"9","key":"10.1016\/j.parint.2021.102298_bb0055","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1017\/S0031182017002025","article-title":"A review on metronidazole: an old warhorse in antimicrobial chemotherapy","volume":"146","author":"Leitsch","year":"2019","journal-title":"Parasitology"},{"issue":"2","key":"10.1016\/j.parint.2021.102298_bb0060","first-page":"66","article-title":"Structure of azomycin (2-nitro-imidazole)","volume":"8","author":"Nakamura","year":"1955","journal-title":"J. Antibiot. Ser. A"},{"issue":"5","key":"10.1016\/j.parint.2021.102298_bb0065","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1248\/cpb1953.3.379","article-title":"Structure of azomycin, a new antibiotic","volume":"3","author":"Nakamura","year":"1955","journal-title":"Pharm. Bull."},{"issue":"4","key":"10.1016\/j.parint.2021.102298_bb0070","first-page":"168","article-title":"Anti-trichomonas effect of azomycin","volume":"9","author":"Horie","year":"1956","journal-title":"J. Antibiot. Ser. A"},{"issue":"2","key":"10.1016\/j.parint.2021.102298_bb0075","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s40265-019-1051-6","article-title":"Fexinidazole: first global approval","volume":"79","author":"Deeks","year":"2019","journal-title":"Drugs"},{"issue":"10","key":"10.1016\/j.parint.2021.102298_bb0080","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1080\/17512433.2018.1509704","article-title":"Clinical and pharmacological profile of benznidazole for treatment of Chagas disease","volume":"11","author":"Kratz","year":"2018","journal-title":"Expert Rev. Clin. Pharmacol."},{"issue":"1093","key":"10.1016\/j.parint.2021.102298_bb0085","doi-asserted-by":"crossref","first-page":"20170915","DOI":"10.1259\/bjr.20170915","article-title":"Nitroimidazoles as hypoxic cell radiosensitizers and hypoxia probes: misonidazole, myths and mistakes","volume":"92","author":"Wardman","year":"2019","journal-title":"Br. J. Radiol."},{"issue":"1","key":"10.1016\/j.parint.2021.102298_bb0090","doi-asserted-by":"crossref","first-page":"24","DOI":"10.7164\/antibiotics.33.24","article-title":"Studies on new phosphonic acid antibiotics. III. Isolation and characterization of FR-31564, FR-32863 and FR-33289","volume":"33","author":"Okuhara","year":"1980","journal-title":"J. Antibiot"},{"issue":"1","key":"10.1016\/j.parint.2021.102298_bb0095","doi-asserted-by":"crossref","first-page":"29","DOI":"10.7164\/antibiotics.33.29","article-title":"Studies on new phosphonic acid antibiotics. IV. Structure determination of FR-33289, FR-31564 and FR-32863","volume":"33","author":"Kuroda","year":"1980","journal-title":"J. Antibiot"},{"issue":"1","key":"10.1016\/j.parint.2021.102298_bb0100","doi-asserted-by":"crossref","first-page":"18","DOI":"10.7164\/antibiotics.33.18","article-title":"Studies on new phosphonic acid antibiotics. II. Taxonomic studies on producing organisms of the phosphonic acid and related compounds","volume":"33","author":"Iguchi","year":"1980","journal-title":"J. Antibiot"},{"issue":"43","key":"10.1016\/j.parint.2021.102298_bb0105","doi-asserted-by":"crossref","first-page":"7913","DOI":"10.1016\/S0040-4039(98)01755-9","article-title":"Fosmidomycin, a specific inhibitor of 1-deoxy-D-xylulose 5-phosphate reductoisomerase in the nonmevalonate pathway for terpenoid biosynthesis","volume":"39","author":"Kuzuyama","year":"1998","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.parint.2021.102298_bb0110","doi-asserted-by":"crossref","unstructured":"H. Jomaa, J. Wiesner, S. Sanderbrand, B. Altincicek, C. Weidemeyer, M. Hintz, I. T\u00fcrbachova, M. Eberl, J. Zeidler, H. K. Lichtenthaler, D. Soldati, E. Beck, Inhibitors of the nonmevalonate pathway of isoprenoid biosynthesis as antimalarial drugs. Science 285 (5433) (1999) 1573\u20131576, https:\/\/doi.10.1126\/science.285.5433.1573.","DOI":"10.1126\/science.285.5433.1573"},{"issue":"12","key":"10.1016\/j.parint.2021.102298_bb0115","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1093\/cid\/cix1122","article-title":"Efficacy and safety of fosmidomycin\u2013piperaquine as nonartemisinin-based combination therapy for uncomplicated falciparum malaria: a single-arm, age de-escalation proof-of-concept study in Gabon","volume":"66","author":"Mombo-Ngoma","year":"2018","journal-title":"Clin. Infect. Dis."},{"issue":"4","key":"10.1016\/j.parint.2021.102298_bb0120","doi-asserted-by":"crossref","first-page":"255","DOI":"10.7164\/antibiotics.21.255","article-title":"Streptomyces citricolor nov. sp. and a new antibiotic, aristeromycin","volume":"21","author":"Kusaka","year":"1968","journal-title":"J. Antibiot"},{"issue":"4","key":"10.1016\/j.parint.2021.102298_bb0125","doi-asserted-by":"crossref","first-page":"359","DOI":"10.7164\/antibiotics.34.359","article-title":"Studies on neplanocin A, new antitumor antibiotic. I. Producing organism, isolation and characterization","volume":"34","author":"Yaginuma","year":"1981","journal-title":"J. Antibiot"},{"issue":"6","key":"10.1016\/j.parint.2021.102298_bb0130","doi-asserted-by":"crossref","first-page":"675","DOI":"10.7164\/antibiotics.34.675","article-title":"Studies on neplanocin A, new antitumor antibiotic. II. Structure determination","volume":"34","author":"Hayashi","year":"1981","journal-title":"J. Antibiot"},{"issue":"7","key":"10.1016\/j.parint.2021.102298_bb0135","doi-asserted-by":"crossref","first-page":"4353","DOI":"10.1016\/S0021-9258(17)43053-5","article-title":"A potent inhibitor of S-adenosylhomocysteine hydrolase and of vaccinia virus multiplication in mouse L929 cells","volume":"259","author":"Borchardt","year":"1984","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.parint.2021.102298_bb0140","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0022-3565(25)38806-3","article-title":"Antimalarial activity of neplanocin A with perturbations in the metabolism of purines, polyamines and S-adenosylmethionine","volume":"236","author":"Whaun","year":"1986","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"22","key":"10.1016\/j.parint.2021.102298_bb0145","doi-asserted-by":"crossref","first-page":"3963","DOI":"10.1016\/j.bmcl.2003.08.074","article-title":"Synthesis of 2-fluoronoraristeromycin and its inhibitory activity against Plasmodium falciparum S-adenosyl-L-homocysteine hydrolase","volume":"13","author":"Kitade","year":"2003","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"25","key":"10.1016\/j.parint.2021.102298_bb0150","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1016\/S0040-4039(01)84869-3","article-title":"Ascofuranone, a new antibiotic from Ascochyta viciae","volume":"13","author":"Sasaki","year":"1972","journal-title":"Tetrahedron Lett."},{"issue":"11","key":"10.1016\/j.parint.2021.102298_bb0155","doi-asserted-by":"crossref","first-page":"676","DOI":"10.7164\/antibiotics.26.676","article-title":"Isolation and structure of ascofuranone and ascofranol, antibiotics with hypolipidemic activity","volume":"26","author":"Sasaki","year":"1973","journal-title":"J. Antibiot."},{"issue":"3","key":"10.1016\/j.parint.2021.102298_bb0160","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/ja.2016.132","article-title":"Re-identification of the ascofuranone-producing fungus Ascochyta viciae as Acremonium sclerotigenum","volume":"70","author":"Hijikawa","year":"2017","journal-title":"J. Antibiot."},{"issue":"2","key":"10.1016\/j.parint.2021.102298_bb0165","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0166-6851(96)02665-5","article-title":"An antibiotic, ascofuranone, specifically inhibits respiration and in vitro growth of long slender bloodstream forms of Trypanosoma brucei brucei","volume":"81","author":"Minagawa","year":"1996","journal-title":"Mol. Biochem. Parasitol."},{"issue":"1","key":"10.1016\/j.parint.2021.102298_bb0170","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.parint.2005.09.003","article-title":"Chemotherapeutic efficacy of ascofuranone in Trypanosoma vivax-infected mice without glycerol","volume":"55","author":"Yabu","year":"2006","journal-title":"Parasitol. Int."},{"issue":"1","key":"10.1016\/j.parint.2021.102298_bb0175","first-page":"38","article-title":"Destomycins A and B, two new antibiotics produced by Streptomyces","volume":"18","author":"Kond\u043e\u0304","year":"1965","journal-title":"J. Antibiot. Ser. A"},{"issue":"1","key":"10.1016\/j.parint.2021.102298_bb0180","doi-asserted-by":"crossref","first-page":"79","DOI":"10.7164\/antibiotics.28.79","article-title":"Structural studies on destomycins A and B","volume":"28","author":"Kondo","year":"1975","journal-title":"J. Antibiot."},{"issue":"11","key":"10.1016\/j.parint.2021.102298_bb0185","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1021\/ja01544a032","article-title":"The isolation of a second antibiotic from Streptomyces hygroscopicus","volume":"80","author":"Mann","year":"1958","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.parint.2021.102298_bb0190","first-page":"9","article-title":"Distribution of the anthelmintic antibiotic, destomycin A, in animals following oral administration. I. Distribution in chickens","volume":"10","author":"Yusa","year":"1968","journal-title":"Meiji Seika Kenkyu Nenpo"},{"key":"10.1016\/j.parint.2021.102298_bb0195","first-page":"1","article-title":"Mode of action of destomycin A","volume":"10","author":"Kojima","year":"1968","journal-title":"Meiji Seika Kenkyu Nenpo"},{"issue":"7","key":"10.1016\/j.parint.2021.102298_bb0200","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/S0092-8674(00)00216-6","article-title":"The structural basis for the action of the antibiotics tetracycline, pactamycin, and hygromycin B on the 30S ribosomal subunit","volume":"103","author":"Brodersen","year":"2000","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.parint.2021.102298_bb0205","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/S0040-4039(00)71964-2","article-title":"Structures of milbemycin \u03b21, \u03b22, and \u03b23","volume":"16","author":"Mishima","year":"1975","journal-title":"Tetrahedron Lett."},{"issue":"5","key":"10.1016\/j.parint.2021.102298_bb0210","doi-asserted-by":"crossref","first-page":"502","DOI":"10.7164\/antibiotics.36.502","article-title":"Milbemycins, a new family of macrolide antibiotics. Fermentation, isolation and physicochemical properties of milbemycins D, E, F, G and H","volume":"36","author":"Takiguchi","year":"1983","journal-title":"J. Antibiot"},{"key":"10.1016\/j.parint.2021.102298_bb0215","first-page":"1","article-title":"Milbemycin: discovery and development","volume":"45","author":"Ide","year":"1993","journal-title":"Annu. Rep. Sankyo Res. Lab."},{"issue":"8","key":"10.1016\/j.parint.2021.102298_bb0220","doi-asserted-by":"crossref","first-page":"980","DOI":"10.7164\/antibiotics.36.980","article-title":"Milbemycins, a new family of macrolide antibiotics. Structure determination of milbemycins D, E, F, G, H, J and K","volume":"36","author":"Mishima","year":"1983","journal-title":"J. Antibiot"},{"issue":"1","key":"10.1016\/j.parint.2021.102298_bb0225","first-page":"69","article-title":"Anthelmintic effect of milbemycin D on parasites in dogs","volume":"17","author":"Sakamoto","year":"1984","journal-title":"J. Fac. Agric. Iwate Univ."},{"key":"10.1016\/j.parint.2021.102298_bb0230","first-page":"60","article-title":"5-Didehydromilbemycin 5-oxime derivatives","author":"Ide","year":"1985","journal-title":"Jpn. Pat."},{"issue":"5","key":"10.1016\/j.parint.2021.102298_bb0235","doi-asserted-by":"crossref","first-page":"692","DOI":"10.7164\/antibiotics.45.692","article-title":"A new anthelmintic cyclodepsipeptide, PF1022A","volume":"45","author":"Sasaki","year":"1992","journal-title":"J. Antibiot."},{"key":"10.1016\/j.parint.2021.102298_bb0240","series-title":"Preparation of didepsipeptides derivatives as anthelmintics, PCT Patent Appl","author":"Nishiyama","year":"1993"},{"issue":"7","key":"10.1016\/j.parint.2021.102298_bb0245","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1096\/fj.00-0664fje","article-title":"Latrophilin-like receptor from the parasitic nematode Haemonchus contortus as target for the anthelmintic depsipeptide PF1022A","volume":"15","author":"Saeger","year":"2001","journal-title":"FASEB J."},{"issue":"14","key":"10.1016\/j.parint.2021.102298_bb0250","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/j.ijpara.2007.05.006","article-title":"The calcium-activated potassium channel, SLO-1, is required for the action of the novel cyclo-octadepsipeptide anthelmintic, emodepside, in Caenorhabditis elegans","volume":"37","author":"Guest","year":"2007","journal-title":"Int. J. Parasitol."},{"issue":"7","key":"10.1016\/j.parint.2021.102298_bb0255","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/nbt978","article-title":"Para-position derivatives of fungal anthelmintic cyclodepsipeptides engineered with Streptomyces venezuelae antibiotic biosynthetic genes","volume":"22","author":"Yanai","year":"2004","journal-title":"Nat. Biotechnol."},{"issue":"2","key":"10.1016\/j.parint.2021.102298_bb0260","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0040-4039(81)80168-2","article-title":"The structure of paraherquamide, a toxic metabolite from Penicillium paraherquei","volume":"22","author":"Yamazaki","year":"1981","journal-title":"Tetrahedron Lett."},{"issue":"2","key":"10.1016\/j.parint.2021.102298_bb0265","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S0034-5288(18)31003-8","article-title":"Efficacy of paraherquamide against immature Trichostrongylus colubriformis in the gerbil (Meriones unguiculatus)","volume":"48","author":"Ostlind","year":"1990","journal-title":"Res. Vet. Sci."},{"key":"10.1016\/j.parint.2021.102298_bb0270","series-title":"Preparation of antiparasitic marcfortines and paraherquamides, PCT Patent Appl","author":"Lee","year":"1993"},{"issue":"3","key":"10.1016\/j.parint.2021.102298_bb0275","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1124\/jpet.102.034272","article-title":"Paraherquamide and 2-deoxy-paraherquamide distinguish cholinergic receptor subtypes in Ascaris muscle","volume":"302","author":"Robertson","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"14","key":"10.1016\/j.parint.2021.102298_bb0280","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1096\/fj.06-6264fje","article-title":"Pharmacology of N-, L- and B-subtypes of nematode nAChR resolved at the single-channel in Ascaris suum","volume":"20","author":"Qian","year":"2006","journal-title":"FASEB J."},{"issue":"12","key":"10.1016\/j.parint.2021.102298_bb0285","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1038\/nrmicro1048","article-title":"The life and times of ivermectin \u2014 a success story","volume":"2","author":"\u014cmura","year":"2004","journal-title":"Nat. Rev. Microbiol."},{"issue":"3","key":"10.1016\/j.parint.2021.102298_bb0290","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1128\/AAC.15.3.361","article-title":"Avermectins, new family of potent anthelmintic agents: producing organism and fermentation","volume":"15","author":"Burg","year":"1979","journal-title":"Antimicrob. Agents Chemother."},{"issue":"3","key":"10.1016\/j.parint.2021.102298_bb0295","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1128\/AAC.15.3.372","article-title":"Avermectins, new family of potent anthelmintic agents: efficacy of the Bla component","volume":"15","author":"Egerton","year":"1979","journal-title":"Antimicrob. Agents Chemother."},{"issue":"6","key":"10.1016\/j.parint.2021.102298_bb0300","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1099\/00207713-52-6-2163","article-title":"Streptomyces avermectinius sp. nov., an avermectin-producing strain","volume":"52","author":"Takahashi","year":"2002","journal-title":"Int. J. Syst. Evol. Microbiol."},{"issue":"14","key":"10.1016\/j.parint.2021.102298_bb0305","doi-asserted-by":"crossref","first-page":"4216","DOI":"10.1021\/ja00404a040","article-title":"Structure determination","volume":"103","author":"Albers-Sch\u00f6enberg","year":"1981","journal-title":"J. Am. Chem. Soc."},{"issue":"5","key":"10.1016\/j.parint.2021.102298_bb0310","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/nbt820","article-title":"Complete genome sequence and comparative analysis of the industrial microorganism Streptomyces avermitilis","volume":"21","author":"Ikeda","year":"2003","journal-title":"Nature Biotech."},{"issue":"10","key":"10.1016\/j.parint.2021.102298_bb0315","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1021\/jm00184a014","article-title":"Ivermectin, a new broad-spectrum antiparasitic agent","volume":"23","author":"Chabala","year":"1980","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.parint.2021.102298_bb0320","series-title":"Macrocyclic Lactones in Antiparasitic Therapy","first-page":"1","article-title":"Ivermectin, abamectin and eprinomectin","author":"Shoop","year":"2002"},{"issue":"12","key":"10.1016\/j.parint.2021.102298_bb0325","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/S1471-4922(01)02112-2","article-title":"Control of onchocerciasis today: status and challenges","volume":"17","author":"Richards","year":"2001","journal-title":"Trends Parasitol."},{"issue":"2","key":"10.1016\/j.parint.2021.102298_bb0330","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1046\/j.1472-8206.2003.00170.x","article-title":"Ivermectin and filariasis","volume":"17","author":"Richard-Lenoble","year":"2003","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.parint.2021.102298_bb0335","series-title":"Macrolide Antibiotics. Chemistry, Biology, and Practice","first-page":"403","article-title":"Ivermectin in clinical practice","author":"Zaha","year":"2002"},{"issue":"9524","key":"10.1016\/j.parint.2021.102298_bb0340","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1016\/S0140-6736(06)68772-2","article-title":"Scabies","volume":"367","author":"Heukelbach","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.parint.2021.102298_bb0345","series-title":"Macrolide Antibiotics. Chemistry, Biology, and Practice","first-page":"571","article-title":"Mode of action of avermectin","author":"\u014cmura","year":"2002"},{"issue":"7349","key":"10.1016\/j.parint.2021.102298_bb0350","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/nature10139","article-title":"Principles of activation and permeation in an anion-selective Cys-loop receptor","volume":"474","author":"Hibbs","year":"2011","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.parint.2021.102298_bb0355","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/0092-8674(94)90212-7","article-title":"Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs","volume":"77","author":"Schinkel","year":"1994","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.parint.2021.102298_bb0360","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2307\/3284141","article-title":"Effect of ivermectin on Caenorhabditis elegans larvae previously exposed to alcoholic immobilization","volume":"82","author":"Smith","year":"1996","journal-title":"J. Parasitol."},{"issue":"2","key":"10.1016\/j.parint.2021.102298_bb0365","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0166-6851(90)90178-O","article-title":"Biophysical transport properties of the cuticle of Ascaris suum","volume":"41","author":"Ho","year":"1990","journal-title":"Mol. Biochem. Parasitol."},{"issue":"6","key":"10.1016\/j.parint.2021.102298_bb0370","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1080\/00034983.1998.11813331","article-title":"In-vitro uptake of ivermectin by adult male Onchocerca ochengi","volume":"92","author":"Cross","year":"1998","journal-title":"Ann. Trop. Med. Parasitol."},{"issue":"1","key":"10.1016\/j.parint.2021.102298_bb0375","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.exppara.2005.12.004","article-title":"Drug transport mechanisms in helminth parasites: passive diffusion of benzimidazole anthelmintics","volume":"113","author":"Mottier","year":"2006","journal-title":"Exp. Parasitol."},{"issue":"5","key":"10.1016\/j.parint.2021.102298_bb0380","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/ja.2017.11","article-title":"Ivermectin: enigmatic multifaceted \u2018wonder\u2019 drug continues to surprise and exceed expectations","volume":"70","author":"Crump","year":"2017","journal-title":"J. Antibiot."},{"issue":"1","key":"10.1016\/j.parint.2021.102298_bb0385","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1590\/S0103-64402004000100015","article-title":"Oral myiasis treated with ivermectin: case report","volume":"15","author":"Shinohara","year":"2004","journal-title":"Braz. Dent. J."},{"issue":"3","key":"10.1016\/j.parint.2021.102298_bb0390","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jemermed.2013.05.014","article-title":"Ivermectin causes Cimex lectularius (Bedbug) morbidity and mortality","volume":"45","author":"Sheele","year":"2013","journal-title":"J. Emerg. Med."},{"issue":"5","key":"10.1016\/j.parint.2021.102298_bb0395","first-page":"564","article-title":"Treatment and eradication of murine fur mites: I. Toxicologic evaluation of ivermectin-compounded feed","volume":"49","author":"Arbona","year":"2010","journal-title":"J. Am. Assoc. Lab. Anim. Sci."},{"key":"10.1016\/j.parint.2021.102298_bb0400","series-title":"Ferrets, Rabbits, and Rodents, Clinical Medicine and Surgery","first-page":"194","article-title":"Dermatologic diseases","author":"Hess","year":"2004"},{"issue":"1\u221210","key":"10.1016\/j.parint.2021.102298_bb0405","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1439-0450.1993.tb00140.x","article-title":"Prevention of cutaneous myiasis caused by screw worm larvae (Cochliomyia hominivorax) using ivermectin","volume":"40","author":"Anziani","year":"1993","journal-title":"J. Veterinary Med. Ser. B"},{"issue":"3","key":"10.1016\/j.parint.2021.102298_bb0410","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3347\/kjp.2013.51.3.297","article-title":"Therapeutic potential of myrrh and ivermectin against experimental Trichinella spiralis infection in mice","volume":"51","author":"Basyoni","year":"2013","journal-title":"Korean J. Parasitol."},{"issue":"10","key":"10.1016\/j.parint.2021.102298_bb0415","first-page":"817","article-title":"Evaluation of the in vivo effect of ivermectin on Schistosoma mansoni in experimentally infected mice","volume":"2","author":"Taman","year":"2014","journal-title":"J. Coastal Life Med."},{"issue":"1","key":"10.1016\/j.parint.2021.102298_bb0420","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4269\/ajtmh.2011.11-0160","article-title":"Ivermectin mass drug administration for humans disrupts malaria parasite transmission in Senegalese villages","volume":"85","author":"Kobylinski","year":"2011","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.parint.2021.102298_bb0425","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/1756-3305-6-165","article-title":"Decrease in survival and fecundity of Glossina palpalis gambiensis vanderplank 1949 (Diptera: Glossinidae) fed on cattle treated with single doses of ivermectin","volume":"6","author":"Pooda","year":"2013","journal-title":"Parasit. Vectors"},{"issue":"8","key":"10.1016\/j.parint.2021.102298_bb0430","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1590\/S0074-02762005000800002","article-title":"Ticks, ivermectin and experimental Chagas disease","volume":"100","author":"Dias","year":"2005","journal-title":"Mem. Inst. Oswaldo Cruz"},{"issue":"2","key":"10.1016\/j.parint.2021.102298_bb0435","doi-asserted-by":"crossref","first-page":"323","DOI":"10.2987\/5678.1","article-title":"Ivermectin as a rodent feed-through insecticide for control of immature sand flies (Diptera: Psychodidae)","volume":"24","author":"Mascari","year":"2008","journal-title":"J. Am. Mosq. Control Assoc."},{"issue":"2","key":"10.1016\/j.parint.2021.102298_bb0440","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/0022-2011(88)90146-2","article-title":"Molluscicidal effect of ivermectin on Biomphalaria glabrata","volume":"52","author":"Matha","year":"1988","journal-title":"J. Invertebr. Pathol."},{"issue":"1","key":"10.1016\/j.parint.2021.102298_bb0445","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1186\/s40064-016-2819-8","article-title":"The efficacy, safety, and tolerability of ivermectin compared with current topical treatments for the inflammatory lesions of rosacea: a network meta-analysis","volume":"5","author":"Siddiqui","year":"2016","journal-title":"Springerplus"},{"issue":"2","key":"10.1016\/j.parint.2021.102298_bb0450","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/tmi.12421","article-title":"Nodding syndrome since 2012: recent progress, challenges and recommendations for future research","volume":"20","author":"Colebunders","year":"2015","journal-title":"Trop. Med. Int. Health"},{"issue":"6","key":"10.1016\/j.parint.2021.102298_bb0455","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s00011-011-0307-8","article-title":"Anti-inflammatory effects of ivermectin in a mouse model of allergic asthma","volume":"60","author":"Yan","year":"2011","journal-title":"Inflamm. Res."},{"issue":"1","key":"10.1016\/j.parint.2021.102298_bb0460","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.nbd.2006.08.018","article-title":"Ivermectin inhibits AMPA receptor-mediated excitotoxicity in cultured motor neurons and extends the life span of a transgenic mouse model of amyotrophic lateral sclerosis","volume":"25","author":"Andries","year":"2007","journal-title":"Neurobiol. Dis."},{"issue":"3","key":"10.1016\/j.parint.2021.102298_bb0465","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0150460","article-title":"Drug repositioning for cancer therapy based on large-scale drug-induced transcriptional signatures","volume":"11","author":"Lee","year":"2016","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.parint.2021.102298_bb0470","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1093\/jac\/dks147","article-title":"Ivermectin is a potent inhibitor of flavivirus replication specifically targeting NS3 helicase activity: new prospects for an old drug","volume":"67","author":"Mastrangelo","year":"2012","journal-title":"J. Antimcrob. Chemother."},{"issue":"3","key":"10.1016\/j.parint.2021.102298_bb0475","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1042\/BJ20120150","article-title":"Ivermectin is a specific inhibitor of importin \u03b1\/\u03b2-mediated nuclear import able to inhibit replication of HIV-1 and dengue viruses","volume":"443","author":"Wagstaff","year":"2012","journal-title":"Biochem. J."},{"key":"10.1016\/j.parint.2021.102298_bb0480","doi-asserted-by":"crossref","first-page":"104787","DOI":"10.1016\/j.antiviral.2020.104787","article-title":"The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro","volume":"178","author":"Caly","year":"2020","journal-title":"Antivir. Res."},{"key":"10.1016\/j.parint.2021.102298_bb0485","series-title":"Review of the emerging evidence demonstrating the efficacy of ivermectin in the prophylaxis and treatment of COVID-19","author":"Kory","year":"2020"},{"issue":"1","key":"10.1016\/j.parint.2021.102298_bb0490","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1021\/ci0200467","article-title":"Property distributions:differences between drugs, natural products, and molecules from combinatorial chemistry","volume":"43","author":"Feher","year":"2003","journal-title":"J. Chem. Inf. Comput. Sci."},{"issue":"3","key":"10.1016\/j.parint.2021.102298_bb0495","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1021\/np200906s","article-title":"Natural products as sources of new drugs over the 30 years from 1981 to 2010","volume":"75","author":"Newman","year":"2012","journal-title":"J. Nat. Prod."},{"issue":"1483","key":"10.1016\/j.parint.2021.102298_bb0500","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1098\/rstb.2007.2044","article-title":"Antibiotics as signalling molecules","volume":"362","author":"Yim","year":"2007","journal-title":"Philos. Trans. R. Soc. B"},{"key":"10.1016\/j.parint.2021.102298_bb0505","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1146\/annurev.mi.46.100192.001251","article-title":"Biodiversity as a source of innovation in biotechnology","volume":"46","author":"Bull","year":"1992","journal-title":"Annu. Rev. Microbiol."},{"issue":"8","key":"10.1016\/j.parint.2021.102298_bb0510","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1038\/ja.2010.87","article-title":"Uncultured microorganisms as a source of secondary metabolites","volume":"63","author":"Lewis","year":"2010","journal-title":"J. Antibiot."},{"issue":"2","key":"10.1016\/j.parint.2021.102298_bb0515","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s10295-013-1389-9","article-title":"Microbial genome mining for accelerated natural products discovery: is a renaissance in the making?","volume":"41","author":"Bachmann","year":"2014","journal-title":"J. Ind. Microbiol. Biotechnol."}],"container-title":["Parasitology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1383576921000179?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1383576921000179?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T10:33:17Z","timestamp":1761301997000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1383576921000179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":103,"alternative-id":["S1383576921000179"],"URL":"https:\/\/doi.org\/10.1016\/j.parint.2021.102298","relation":{},"ISSN":["1383-5769"],"issn-type":[{"value":"1383-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antiparasitic antibiotics from Japan","name":"articletitle","label":"Article Title"},{"value":"Parasitology International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parint.2021.102298","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102298"}}